DelphinusHome PageNews Page Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening Delphinus Medical Technologies, Inc. today announced the closing of a $30 million Series D financing to…Arboretum_JDSeptember 30, 2022
DelphinusNews Page Karmanos Cancer Institute first to receive innovative, FDA-approved SoftVue™ Breast Imaging System The Barbara Ann Karmanos Cancer Institute, the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is the…Arboretum_JDSeptember 27, 2022
DelphinusHome PageNews Page Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has…Arboretum_JDOctober 12, 2021
Delphinus Rachel Brem, M.D. Appointed to Delphinus Board of Directors Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced today that Rachel…Arboretum_JDJuly 31, 2019